These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 17971048)

  • 21. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
    Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
    PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
    Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H
    J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
    Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
    Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
    Cascino I; Paladini F; Belfiore F; Cauli A; Angelini C; Fiorillo MT; Mathieu A; Sorrentino R
    Arthritis Rheum; 2007 Aug; 56(8):2640-51. PubMed ID: 17665395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
    Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
    Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
    Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
    J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
    Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
    Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
    Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
    Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis.
    Compston A; Kellar-Wood H; Wood N
    Baillieres Clin Neurol; 1994 Aug; 3(2):353-71. PubMed ID: 7952852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants in the HLA-G region are associated with Kawasaki disease.
    Kim JJ; Hong SJ; Hong YM; Kim S; Kang MJ; Kim KJ; Seo EJ; Yoo HW; Cheong HS; Shin HD; Park IS; Lee JK
    Hum Immunol; 2008 Dec; 69(12):867-71. PubMed ID: 18976687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association to the Glypican-5 gene in multiple sclerosis.
    Lorentzen AR; Melum E; Ellinghaus E; Smestad C; Mero IL; Aarseth JH; Myhr KM; Celius EG; Lie BA; Karlsen TH; Franke A; Harbo HF
    J Neuroimmunol; 2010 Sep; 226(1-2):194-7. PubMed ID: 20692050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients.
    Bugeja MJ; Booth DR; Bennetts BH; Heard RN; Burgner D; Stewart GJ
    Eur J Hum Genet; 2005 Jul; 13(7):815-22. PubMed ID: 15856071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resequencing of the human major histocompatibility complex in patients with rheumatoid arthritis and healthy controls in Alaska Natives of Southeast Alaska.
    Yan Z; Ferucci ED; Geraghty DE; Yang Y; Lanier AP; Smith WP; Zhao LP; Hansen JA; Nelson JL
    Tissue Antigens; 2007 Dec; 70(6):487-94. PubMed ID: 17990987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis.
    Harney SM; Vilariño-Güell C; Adamopoulos IE; Sims AM; Lawrence RW; Cardon LR; Newton JL; Meisel C; Pointon JJ; Darke C; Athanasou N; Wordsworth BP; Brown MA
    Rheumatology (Oxford); 2008 Dec; 47(12):1761-7. PubMed ID: 18835879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
    Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Roeske D; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
    J Neuroimmunol; 2010 Oct; 227(1-2):162-6. PubMed ID: 20598377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.